Evidence map›Paper›PMID 28119587›Full record

ArticleFrontiers in human neuroscience2016

The Effect of Gray Matter ICA and Coefficient of Variation Mapping of BOLD Data on the Detection of Functional Connectivity Changes in Alzheimer's Disease and bvFTD.

Timo Tuovinen, Riikka Rytty, Virpi Moilanen, Ahmed Abou Elseoud, Juha Veijola, Anne M Remes, Vesa J Kiviniemi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in human neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. FTD spectrum: Neuroimaging across the FTD spectrum.Progress in molecular biology and translational science · 2019
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Timo TuovinenDepartment of Diagnostic Radiology, Oulu University HospitalOulu, Finland; Oulu Functional NeuroImaging group, Research Unit of Medical Imaging, Physics and Technology, the Faculty of Medicine, University of OuluOulu, Finland; Medical Research Center Oulu, Oulu University HospitalOulu, Finland.
Riikka RyttyDepartment of Diagnostic Radiology, Oulu University HospitalOulu, Finland; Oulu Functional NeuroImaging group, Research Unit of Medical Imaging, Physics and Technology, the Faculty of Medicine, University of OuluOulu, Finland; Medical Research Center Oulu, Oulu University HospitalOulu, Finland; Research Unit of Clinical Neuroscience, Faculty of Medicine, University of OuluOulu, Finland.
Virpi MoilanenResearch Unit of Clinical Neuroscience, Faculty of Medicine, University of Oulu Oulu, Finland.
Ahmed Abou ElseoudDepartment of Diagnostic Radiology, Oulu University HospitalOulu, Finland; Oulu Functional NeuroImaging group, Research Unit of Medical Imaging, Physics and Technology, the Faculty of Medicine, University of OuluOulu, Finland.
Juha VeijolaMedical Research Center Oulu, Oulu University HospitalOulu, Finland; Research Unit of Clinical Neuroscience, Faculty of Medicine, University of OuluOulu, Finland.
Anne M RemesMedical Research Center Oulu, Oulu University HospitalOulu, Finland; Department of Neurology, Institute of Clinical Medicine, University of Eastern FinlandKuopio, Finland; Department of Neurology, Kuopio University HospitalKuopio, Finland.
Vesa J KiviniemiDepartment of Diagnostic Radiology, Oulu University HospitalOulu, Finland; Oulu Functional NeuroImaging group, Research Unit of Medical Imaging, Physics and Technology, the Faculty of Medicine, University of OuluOulu, Finland; Medical Research Center Oulu, Oulu University HospitalOulu, Finland.
Oulu University Hospital · FIUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resting-state fMRI results in neurodegenerative diseases have been somewhat conflicting. This may be due to complex partial volume effects of CSF in BOLD signal in patients with brain atrophy. To encounter this problem, we used a coefficient of variation (CV) map to highlight artifacts in the data, followed by analysis of gray matter voxels in order to minimize brain volume effects between groups. The effects of these measures were compared to whole brain ICA dual regression results in Alzheimer's disease (AD) and behavioral variant frontotemporal dementia (bvFTD). 23 AD patients, 21 bvFTD patients and 25 healthy controls were included. The quality of the data was controlled by CV mapping. For detecting functional connectivity (FC) differences whole brain ICA (wbICA) and also segmented gray matter ICA (gmICA) followed by dual regression were conducted, both of which were performed both before and after data quality control. Decreased FC was detected in posterior DMN in the AD group and in the Salience network in the bvFTD group after combining CV quality control with gmICA. Before CV quality control, the decreased connectivity finding was not detectable in gmICA in neither of the groups. Same finding recurred when exclusion was based on randomization. The subjects excluded due to artifacts noticed in the CV maps had significantly lower temporal signal-to-noise ratio than the included subjects. Data quality measure CV is an effective tool in detecting artifacts from resting state analysis. CV reflects temporal dispersion of the BOLD signal stability and may thus be most helpful for spatial ICA, which has a blind spot in spatially correlating widespread artifacts. CV mapping in conjunction with gmICA yields results suiting previous findings both in AD and bvFTD.

Indexed as

Alzheimer’s diseasebehavioral variant frontotemporal dementiacoefficient of variationgray matterindependent component analysisquality controlresting-state fMRI

Identifiers

PMID28119587
PMCPMC5220074
OpenAlexW2571274079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.